“This study demonstrates that gradually increasing the dose from a low, well-tolerated starting dose enables Nexvax2 to be safe and tolerable without dose-limiting adverse events at a level of 900 μg, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results